| Literature DB >> 29158377 |
Jenny Erales1,2, Virginie Marchand3, Baptiste Panthu2,4,5, Sandra Gillot6, Stéphane Belin1,2, Sandra E Ghayad1,2, Maxime Garcia1,2, Florian Laforêts1,2, Virginie Marcel1,2, Agnès Baudin-Baillieu6, Pierre Bertin6, Yohann Couté7, Annie Adrait7, Mélanie Meyer8, Gabriel Therizols1,2, Marat Yusupov9, Olivier Namy6, Théophile Ohlmann2,4,5, Yuri Motorin9, Frédéric Catez10,2, Jean-Jacques Diaz10,2.
Abstract
Ribosomal RNAs (rRNAs) are main effectors of messenger RNA (mRNA) decoding, peptide-bond formation, and ribosome dynamics during translation. Ribose 2'-O-methylation (2'-O-Me) is the most abundant rRNA chemical modification, and displays a complex pattern in rRNA. 2'-O-Me was shown to be essential for accurate and efficient protein synthesis in eukaryotic cells. However, whether rRNA 2'-O-Me is an adjustable feature of the human ribosome and a means of regulating ribosome function remains to be determined. Here we challenged rRNA 2'-O-Me globally by inhibiting the rRNA methyl-transferase fibrillarin in human cells. Using RiboMethSeq, a nonbiased quantitative mapping of 2'-O-Me, we identified a repertoire of 2'-O-Me sites subjected to variation and demonstrate that functional domains of ribosomes are targets of 2'-O-Me plasticity. Using the cricket paralysis virus internal ribosome entry site element, coupled to in vitro translation, we show that the intrinsic capability of ribosomes to translate mRNAs is modulated through a 2'-O-Me pattern and not by nonribosomal actors of the translational machinery. Our data establish rRNA 2'-O-Me plasticity as a mechanism providing functional specificity to human ribosomes.Entities:
Keywords: 2′-O-methylation; RNA epigenetics; fibrillarin; ribosomal RNA; translational control
Mesh:
Substances:
Year: 2017 PMID: 29158377 PMCID: PMC5724255 DOI: 10.1073/pnas.1707674114
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205